0 software. Subgroup analysis and sensitivity analysis were also carried out. Results: 55 RCTs involving a total of 8449 participants met the inclusion criteria. Compared with the non-probiotics anti-H. pylori regimens, probiotics significantly mTOR inhibitor increased the eradication rate. The pooled RR by intention-to-treat and by perprotocol analysis in the probiotics supplementation versus without probiotics was 1.15[95% confidence interval (CI), 1.12–1.19]

and1.14 (95% CI, 1.11–1.17), respectively. And reduced the risk of overall H. pylori therapy related adverse effects (RR0.48, 95% CI,0.38–0.60). In addition, There are no significant differences for the eradication rate of H. pylori whenever you add probiotics. The pooled RR(itt) is 1.17 (95% CI, 1.09–1.26) (using probiotics as a pretreatment),1.14 (95% CI, 1.10–1.19) (using probiotics after regular non-probiotics selleck screening library therapy), 1.16 (95% CI, 1.10–1.21) (using probiotics in the same time with the regular non-probiotics therapy). Conclusion: The supplementation with probiotics during H. pylori eradication therapy may be effective in increasing eradication rates and decreasing therapy-related side effects. In addition, the probiotics may have similar effects on eradication rates whenever they are added. Key Word(s): 1. Meta-analysis; 2. Helicobacter pylori; 3. eradication; 4. probiotics; Presenting Author:

JINGTONG WANG Additional Authors: LAN YAO, XIANGHAI ZHOU, ZHENYU ZHANG, QIAN XUE, LINONG JI, YULAN LIU Corresponding Author: YULAN LIU Affiliations: Department of Gastroenterology, Peking University People’s Hospital; Department of Gastroenterology, Department of Gastroenterology, Peking University People’s Hospital Objective: At present,

the literature on the relationship between helicobacter pylori (Hp) infection and type 2 diabetes mellitus (T2DM) is inconsistent. We investigated serum Hp IgG positive rate and Hp infection rate in T2DM patients; we also explored the difference of related metabolic markers between Hp (+) group and Hp (−) group. Methods: 795 residents in Pinggu District, Beijing, China were selected and their socio-demographic factors, levels of serum Hp IgG, diagnosis of T2DM and related metabolic markers were investigated. Thiamet G Another 127 patients taking endoscopy examination in our hospital were also selected and we investigated their socio-demographic factors, rapid urease test, levels of serum Hp IgG, histopathological examination, diagnosis of T2DM and related metabolic markers. We used t test or non-parametric test, χ2 test and logistic regression to explore the association between Hp infection and T2DM. Results: By applying serous diagnostic criteria of Hp infection and excluding confounding or potential confounding factors, we find that there is no significant difference of Hp infection rate between T2DM patients and non-T2DM ones (p > 0.05, T2DM 32.47%, non-T2DM 42.